IRVINE, Calif., Nov. 21, 2011 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX - News), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences and Bob Krist, Chief Financial Officer, is scheduled to present at one upcoming conference. The first presentation will be at the 23rd Annual Piper Jaffray Health Care Conference in New York City.
